Recital 7, Decision_act (EU) 2015/1873

In forcesince 8 Oct 2015

There is no prevalence data on the use of 4,4′-DMAR. However, the information available suggests that it has not been widely used. Information obtained from cases involving death also suggests that users unknowingly consumed 4,4′-DMAR when seeking other stimulants.